I migliori medici per il trattamento di Metastasi epatiche - TOP-10 medici

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center, uno dei principali centri oncologici di Israele.

• Oltre 20 anni di esperienza specializzata in oncologia ortopedica
• Fellowship nel trattamento dei sarcomi presso l'Institut Gustave Roussy, Parigi
• Ricercatore senior presso il Weizmann Institute e l'Università di Tel Aviv
• Membro attivo dell'ESMO nella facoltà di sarcomi
• Ha pubblicato numerosi studi sui risultati del trattamento del cancro

La Dott.ssa Pelles Sharon dirige l'Istituto dei Tumori Gastrointestinali presso il Centro Medico Sourasky, leader nel trattamento delle metastasi epatiche.

• Specializzata nel trattamento sistemico dei tumori gastrointestinali
• Formata in oncologia presso il Royal Marsden Cancer Center di Londra
• Ha sviluppato nuovi metodi per il trattamento dell'adenocarcinoma pancreatico
• Ha condotto ricerche molecolari rivoluzionarie sui tumori delle vie biliari

Il dottor Ari Raphael guida l'Iniziativa Nazionale di Medicina Genomica presso il Sourasky Medical Center, specializzandosi in trattamenti oncologici avanzati.

• Docente senior con ampie ricerche in genomica e informatica biomedica
• Investigatore principale per molteplici studi clinici sul cancro al polmone e alla mammella
• Membro della Società Europea di Oncologia Medica (ESMO) e dell'Associazione Internazionale per lo Studio del Cancro al Polmone (IASLC)
• Vincitore di numerosi riconoscimenti per l'insegnamento e la ricerca

Dirige la Divisione di Oncologia Medica presso il Sourasky Medical Center, un ospedale di primo piano per la cura complessa dei tumori.

• Oncologo senior con vasta esperienza clinica e di ricerca
• Esperto nel trattamento delle metastasi epatiche
• Formazione in medicina interna per una cura complessiva del corpo
• Fluente in inglese per una comunicazione chiara

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

EDUCATION AND ADVANCED TRAINING COURSES

• 1989 - received higher medical education at the Hebrew University;
• 1995 - completed residency in internal medicine and gastroenterology at the Hadassah University Hospital.
• 2001 - 2002 - Internship with Professor Scott Friedman in the Department of Liver Diseases at Sinai School of Medicine in New York.

Today, Professor Rifaat Safadi is an outstanding specialist in the field of liver disease treatment, a member of the committee for the development of the somatic cell transplant center and the head of the liver disease unit at Hadassah Medical Center. The professor is a member of several international associations for the study of the liver and is the author of numerous articles in his specialty. Professor Safadi is a member of the editorial board of the scientific medical journal Clinical Science.

Rifaat Safadi is a laureate of many scientific awards. In particular, he has been repeatedly awarded the Hadassah Prize for studying the process of immune modulation of liver fibrosis using mRNA. For achievements in the same field, the professor received the Sharon Donsky and the Israeli Association of Gastroenterology and Hepatology awards.